THE EFFECTS OF A RANGE OF ANTICANCER DRUGS IN THE WHITE-IVORY SOMATIC MUTATION TEST IN DROSOPHILA

被引:22
作者
CLEMENTS, J
HOWE, D
LOWRY, A
PHILLIPS, M
机构
[1] UNIV EXETER,WASHINGTON SINGER LABS,DEPT BIOL SCI,EXETER EX4 4QG,DEVON,ENGLAND
[2] TAUNTON & SOMERSET HOSP,MUSGROVE PK BRANCH,TAUNTON TA1 5DA,SOMERSET,ENGLAND
来源
MUTATION RESEARCH | 1990年 / 228卷 / 02期
关键词
D O I
10.1016/0027-5107(90)90073-D
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The white-ivory test is based upon the reversion of the X-linked, recessive eye-colour mutation white-ivory to wild-type. Somatic reversion of white-ivory results in clones of red facets in the white-ivory eyes of eclosing adult files. 4 anti-cancer drugs, bleomycin, adriamycin, mitoxantrone and cyclophosphamide were found to significantly increase the white-ivory reversion frequency whereas cytosine arabinoside, methotrexate and vincristine did not give positive results. © 1990.
引用
收藏
页码:171 / 176
页数:6
相关论文
共 24 条
[11]   TABLES FOR DETERMINING STATISTICAL SIGNIFICANCE OF MUTATION FREQUENCIES [J].
KASTENBAUM, MA ;
BOWMAN, KO .
MUTATION RESEARCH, 1970, 9 (05) :527-+
[12]  
LINDSLEY DL, 1985, DROSOPHILA INF SERV, P62
[13]  
LINDSLEY DL, 1968, CARNEGIE I WASH PUBL, V267
[14]  
LOCK RB, 1987, ANTI-CANCER DRUG DES, V2, P151
[15]  
ROSNER F, 1983, B CANCER, V70, P55
[16]   MITOXANTRONE - A NEW ANTICANCER DRUG WITH SIGNIFICANT CLINICAL ACTIVITY [J].
SHENKENBERG, TD ;
VONHOFF, DD .
ANNALS OF INTERNAL MEDICINE, 1986, 105 (01) :67-81
[17]  
SIEBER SM, 1975, ADV CANCER RES, V22, P55
[18]   OCCUPATIONAL EXPOSURE TO ANTICANCER DRUGS - POTENTIAL AND REAL HAZARDS [J].
SORSA, M ;
HEMMINKI, K ;
VAINIO, H .
MUTATION RESEARCH, 1985, 154 (02) :135-149
[19]   LATE DEATHS AND 2ND PRIMARY MALIGNANCIES AMONG LONG-TERM SURVIVORS OF CHILDHOOD-CANCER - AN ITALIAN MULTICENTER STUDY [J].
TERRACINI, B ;
PASTORE, G ;
ZURLO, MG ;
MASERA, G ;
FOSSATIBELLANI, F ;
CASTELLO, M ;
TAMARO, P ;
MASSOLO, F ;
ROSATI, D ;
BIDDAU, PF ;
RUSSO, A .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (05) :499-504
[20]   LEUKEMIA AFTER THERAPY WITH ALKYLATING-AGENTS FOR CHILDHOOD-CANCER [J].
TUCKER, MA ;
MEADOWS, AT ;
BOICE, JD ;
STOVALL, M ;
OBERLIN, O ;
STONE, BJ ;
BIRCH, J ;
VOUTE, PA ;
HOOVER, RN ;
FRAUMENI, JF .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1987, 78 (03) :459-464